Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma
Several studies have demonstrated the negative impact of radiotherapy protocol deviations on tumor control in medulloblastoma. In the SIOP PNET5 MB trial, a pretreatment radiotherapy quality control (RT-QC) program was introduced. A first analysis for patients enrolled in Germany, Switzerland and Au...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2021
|
| In: |
Strahlentherapie und Onkologie
Year: 2021, Volume: 197, Issue: 8, Pages: 674-682 |
| ISSN: | 1439-099X |
| DOI: | 10.1007/s00066-020-01707-8 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00066-020-01707-8 |
| Author Notes: | Stefan Dietzsch, Annett Braesigk, Clemens Seidel, Julia Remmele, Ralf Kitzing, Tina Schlender, Martin Mynarek, Dirk Geismar, Karolina Jablonska, Rudolf Schwarz, Montserrat Pazos, Marc Walser, Silke Frick, Kristin Gurtner, Christiane Matuschek, Semi Ben Harrabi, Albrecht Glück, Victor Lewitzki, Karin Dieckmann, Martin Benesch, Nicolas U. Gerber, Stefan Rutkowski, Beate Timmermann, Rolf-Dieter Kortmann |
| Summary: | Several studies have demonstrated the negative impact of radiotherapy protocol deviations on tumor control in medulloblastoma. In the SIOP PNET5 MB trial, a pretreatment radiotherapy quality control (RT-QC) program was introduced. A first analysis for patients enrolled in Germany, Switzerland and Austria with focus on types of deviations in the initial plan proposals and review criteria for modern radiation technologies was performed. |
|---|---|
| Item Description: | Online veröffentlicht: 23. November 2020 Gesehen am 23.02.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1439-099X |
| DOI: | 10.1007/s00066-020-01707-8 |